Axsome Therapeutics Inc (AXSM)
87.15
-1.69
(-1.90%)
USD |
NASDAQ |
Nov 04, 16:00
87.16
+0.01
(+0.01%)
After-Hours: 20:00
Axsome Therapeutics Total Liabilities (Quarterly): 445.37M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 445.37M |
| March 31, 2024 | 401.69M |
| December 31, 2023 | 397.26M |
| September 30, 2023 | 331.35M |
| June 30, 2023 | 332.83M |
| March 31, 2023 | 277.37M |
| December 31, 2022 | 221.92M |
| September 30, 2022 | 181.60M |
| June 30, 2022 | 165.36M |
| March 31, 2022 | 73.86M |
| December 31, 2021 | 72.15M |
| September 30, 2021 | 73.88M |
| June 30, 2021 | 71.83M |
| March 31, 2021 | 70.61M |
| December 31, 2020 | 72.34M |
| September 30, 2020 | 68.37M |
| June 30, 2020 | 36.75M |
| March 31, 2020 | 41.64M |
| December 31, 2019 | 41.83M |
| Date | Value |
|---|---|
| September 30, 2019 | 37.62M |
| June 30, 2019 | 30.49M |
| March 31, 2019 | 26.53M |
| December 31, 2018 | 14.44M |
| September 30, 2018 | 15.38M |
| June 30, 2018 | 14.72M |
| March 31, 2018 | 15.35M |
| December 31, 2017 | 18.84M |
| September 30, 2017 | 15.78M |
| June 30, 2017 | 16.29M |
| March 31, 2017 | 17.13M |
| December 31, 2016 | 16.64M |
| September 30, 2016 | 6.736M |
| June 30, 2016 | 5.104M |
| March 31, 2016 | 3.914M |
| December 31, 2015 | 2.632M |
| September 30, 2015 | 2.234M |
| June 30, 2015 | 14.09M |
| December 31, 2014 | 5.989M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
36.75M
Minimum
Jun 2020
445.37M
Maximum
Jun 2024
177.79M
Average
73.88M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Krystal Biotech Inc | 78.76M |
| Pfizer Inc | 128.22B |
| Sarepta Therapeutics Inc | 2.347B |
| Moderna Inc | 3.968B |
| NovaBay Pharmaceuticals Inc | 4.542M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 548.23M |
| Shareholders Equity (Quarterly) | 102.85M |
| Debt to Equity Ratio | 1.744 |
| Current Ratio | 2.482 |
| Net Debt Paydown Yield | -0.16% |